Pdt Partners, LLC Bluebird Bio, Inc. Transaction History

Pdt Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.77 - $8.49 $598,308 - $880,353	-103,693 Reduced 39.46%	159,074 $1.1 Million
Q3 2022 Nov 14, 2022	SELL	$3.75 - $7.39 $962,662 - $1.9 Million	-256,710 Reduced 49.42%	262,767 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $23 - $41	-8 Reduced -0.0%	519,477 $2.15 Million
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $881,696 - $2.3 Million	216,633 Added 71.53%	519,485 $2.52 Million
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $1.18 Million - $2.14 Million	131,152 Added 76.38%	302,852 $3.03 Million
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $945,284 - $1.77 Million	84,100 Added 96.0%	171,700 $3.28 Million
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $505,192 - $618,608	28,004 Added 46.99%	87,600 $2.8 Million
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $430,062 - $878,530	-25,923 Reduced 30.31%	59,596 $1.8 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $390,500 - $538,464	14,200 Added 19.91%	85,519 $3.7 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $398,849 - $506,668	-11,581 Reduced 13.97%	71,319 $3.85 Million
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $569,520 - $965,370	-21,000 Reduced 20.21%	82,900 $5.06 Million
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $4.88 Million - $6.41 Million	103,900 New	103,900 $9.12 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.